The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Hironori Harada

Department of Hematology and Oncology

Hiroshima University

Hiroshima

Japan

[email]@hiroshima-u.ac.jp

Name/email consistency: low

 
 
 
 
 
 
 

Affiliations

  • Department of Hematology and Oncology, Hiroshima University, Hiroshima, Japan. 2009
  • Department of Molecular Oncology and the Department of Hematology/Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan. 2003 - 2006

References

  1. Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality. Harada, H., Watanabe, M., Suzuki, K., Yanagita, S., Suzuki, T., Yoshida, Y., Kimura, A., Tsudo, M., Matsuda, A., Tohyama, K., Taniwaki, M., Takeshita, K., Takatoku, M., Ozawa, K. Int. J. Hematol. (2009) [Pubmed]
  2. Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS. Harada, H., Harada, Y., Kimura, A. Curr. Cancer. Drug. Targets (2006) [Pubmed]
  3. Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome. Harada, H., Harada, Y. Crit. Rev. Eukaryot. Gene Expr. (2005) [Pubmed]
  4. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. Harada, H., Harada, Y., Niimi, H., Kyo, T., Kimura, A., Inaba, T. Blood (2004) [Pubmed]
  5. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia. Harada, H., Harada, Y., Tanaka, H., Kimura, A., Inaba, T. Blood (2003) [Pubmed]
 
WikiGenes - Universities